{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:29:15Z","timestamp":1792747755274,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK132259"],"award-info":[{"award-number":["R01 DK132259"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2-SRA-2024-1460-M-B"],"award-info":[{"award-number":["2-SRA-2024-1460-M-B"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","award":["222D800030"],"award-info":[{"award-number":["222D800030"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007674","name":"Institute of Molecular and Cell Biology","doi-asserted-by":"publisher","award":["HLTRP\/2022\/NUS-IMCB-02"],"award-info":[{"award-number":["HLTRP\/2022\/NUS-IMCB-02"]}],"id":[{"id":"10.13039\/501100007674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007674","name":"Institute of Molecular and Cell Biology","doi-asserted-by":"publisher","award":["H22G0a0005"],"award-info":[{"award-number":["H22G0a0005"]}],"id":[{"id":"10.13039\/501100007674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007674","name":"Institute of Molecular and Cell Biology","doi-asserted-by":"publisher","award":["OFIRG21jun-0097"],"award-info":[{"award-number":["OFIRG21jun-0097"]}],"id":[{"id":"10.13039\/501100007674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007674","name":"Institute of Molecular and Cell Biology","doi-asserted-by":"publisher","award":["SC36\/19-000801-A044"],"award-info":[{"award-number":["SC36\/19-000801-A044"]}],"id":[{"id":"10.13039\/501100007674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007674","name":"Institute of Molecular and Cell Biology","doi-asserted-by":"publisher","award":["CSASI21jun-0006"],"award-info":[{"award-number":["CSASI21jun-0006"]}],"id":[{"id":"10.13039\/501100007674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007674","name":"Institute of Molecular and Cell Biology","doi-asserted-by":"publisher","award":["MTCIRG21-0071"],"award-info":[{"award-number":["MTCIRG21-0071"]}],"id":[{"id":"10.13039\/501100007674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007674","name":"Institute of Molecular and Cell Biology","doi-asserted-by":"publisher","award":["H24G1a0015"],"award-info":[{"award-number":["H24G1a0015"]}],"id":[{"id":"10.13039\/501100007674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007674","name":"Institute of Molecular and Cell Biology","doi-asserted-by":"publisher","award":["HLCA23Feb-0031"],"award-info":[{"award-number":["HLCA23Feb-0031"]}],"id":[{"id":"10.13039\/501100007674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007674","name":"Institute of Molecular and Cell Biology","doi-asserted-by":"publisher","award":["I22D1AG053"],"award-info":[{"award-number":["I22D1AG053"]}],"id":[{"id":"10.13039\/501100007674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.molmed.2024.09.005","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T12:31:51Z","timestamp":1729254711000},"page":"152-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The role of glucose-6-phosphatase activity in glucose homeostasis and its potential for diabetes therapy"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9382-1933","authenticated-orcid":false,"given":"Lay Shuen","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1227-7798","authenticated-orcid":false,"given":"Hwee Hui","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7764-6772","authenticated-orcid":false,"given":"Essam M.","family":"Abdelalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1601-2391","authenticated-orcid":false,"given":"Chin Meng","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2153-9761","authenticated-orcid":false,"given":"Richard M.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2929-8966","authenticated-orcid":false,"given":"E. Shyong","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5901-7075","authenticated-orcid":false,"given":"Adrian Kee Keong","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2024.09.005_bb0005","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diabetes.51.6.1663","article-title":"Direct and indirect effects of insulin on glucose uptake and storage by the liver","volume":"51","author":"Satake","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2024.09.005_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1189\/jlb.1VMR1216-535R","article-title":"Energy metabolic pathways control the fate and function of myeloid immune cells","volume":"102","author":"Al-Khami","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cphy.c130024","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1051\/rnd:19960402","article-title":"Role of glucokinase and glucose-6 phosphatase in the nutritional regulation of endogenous glucose production","volume":"36","author":"Mithieux","year":"1996","journal-title":"Reprod. Nutr. Dev."},{"key":"10.1016\/j.molmed.2024.09.005_bb0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fphys.2019.00148","article-title":"The central role of glucokinase in glucose homeostasis: a perspective 50 years after demonstrating the presence of the enzyme in islets of Langerhans","volume":"10","author":"Matschinsky","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0030","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.bbagen.2012.12.013","article-title":"Multiple roles of glucose-6-phosphatases in pathophysiology: state of the art and future trends","volume":"1830","author":"Marcolongo","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2024.09.005_bb0035","doi-asserted-by":"crossref","first-page":"29241","DOI":"10.1074\/jbc.R109.025544","article-title":"Glucose-6-phosphatase catalytic subunit gene family","volume":"284","author":"Hutton","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.09.005_bb0040","doi-asserted-by":"crossref","first-page":"39982","DOI":"10.1074\/jbc.M605858200","article-title":"Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)\/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.09.005_bb0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/dc18-1773","article-title":"Long-term absolute risk for cardiovascular disease stratified by fasting glucose level","volume":"42","author":"Bancks","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmed.2024.09.005_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12933-021-01265-y","article-title":"Association of fasting glucose with lifetime risk of incident heart failure: the Lifetime Risk Pooling Project","volume":"20","author":"Sinha","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026010","article-title":"Low fasting glucose and future risks of major adverse outcomes in people without baseline diabetes or cardiovascular disease: a systematic review and meta-analysis","volume":"9","author":"Liao","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.molmed.2024.09.005_bb0060","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJMoa050080","article-title":"Normal fasting plasma glucose levels and type 2 diabetes in young men","volume":"353","author":"Tirosh","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2024.09.005_bb0065","doi-asserted-by":"crossref","first-page":"e4448","DOI":"10.1210\/clinem\/dgab466","article-title":"Fasting plasma glucose and incident colorectal cancer: analysis of a nationwide epidemiological database","volume":"106","author":"Itoh","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.09.005_bb0070","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4143\/crt.2020.817","article-title":"Fasting blood glucose, cholesterol, and risk of primary liver cancer: the Kailuan Study","volume":"53","author":"Ma","year":"2021","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.molmed.2024.09.005_bb0075","article-title":"Fasting blood glucose and risk of incident pancreatic cancer","volume":"17","author":"Kim","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2024.09.005_bb0080","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","article-title":"The trans-ancestral genomic architecture of glycemic traits","volume":"53","author":"Chen","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2024.09.005_bb0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nyas.13435","article-title":"Insulin regulation of gluconeogenesis","volume":"1411","author":"Hatting","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molmed.2024.09.005_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.biocel.2011.10.001","article-title":"Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis","volume":"44","author":"Jitrapakdee","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0095","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/ckj\/sfad046","article-title":"Gluconeogenesis in the kidney: in health and in chronic kidney disease","volume":"16","author":"Dalga","year":"2023","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.molmed.2024.09.005_bb0100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.biochi.2023.11.012","article-title":"Intestinal gluconeogenesis: a translator of nutritional information needed for glycemic and emotional balance","volume":"223","author":"Gautier-Stein","year":"2024","journal-title":"Biochimie"},{"key":"10.1016\/j.molmed.2024.09.005_bb0105","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cmet.2017.04.032","article-title":"Gut-brain glucose signaling in energy homeostasis","volume":"25","author":"Soty","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2024.09.005_bb0110","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.3390\/nu13113828","article-title":"Glycogen storage disease type Ia: current management options, burden and unmet needs","volume":"13","author":"Derks","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.molmed.2024.09.005_bb0115","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3302774","article-title":"Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia","volume":"13","author":"Koeberl","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.molmed.2024.09.005_bb0120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.gt.3302650","article-title":"Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer","volume":"13","author":"Ghosh","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.molmed.2024.09.005_bb0125","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10545-018-0223-y","article-title":"Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy","volume":"41","author":"Brooks","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.molmed.2024.09.005_bb0130","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/hep.25717","article-title":"Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy","volume":"56","author":"Lee","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2024.09.005_bb0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymgme.2017.01.003","article-title":"Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-\u03b1 activity restored are at risk of developing hepatic tumors","volume":"120","author":"Kim","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2024.09.005_bb0140","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1089\/hum.2019.102","article-title":"Challenges of gene therapy for the treatment of glycogen storage diseases type I and type III","volume":"30","author":"Jauze","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.molmed.2024.09.005_bb0145","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/jimd.12660","article-title":"CRISPR\/Cas9-based double-strand oligonucleotide insertion strategy corrects metabolic abnormalities in murine glycogen storage disease type-Ia","volume":"46","author":"Samanta","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.molmed.2024.09.005_bb0150","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1038\/s41467-021-23318-2","article-title":"mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease","volume":"12","author":"Cao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.09.005_bb0155","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1093\/hmg\/ddz133","article-title":"Gene therapy for glycogen storage diseases","volume":"28","author":"Kishnani","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2024.09.005_bb0160","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/diabetes.48.3.531","article-title":"Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein","volume":"48","author":"Arden","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2024.09.005_bb0165","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.cmet.2016.08.018","article-title":"RNA sequencing of single human islet cells reveals type 2 diabetes genes","volume":"24","author":"Xin","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2024.09.005_bb0170","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2337\/diabetes.50.3.502","article-title":"Characterization of the mouse islet-specific glucose-6-phosphatase catalytic subunit-related protein gene promoter by in situ footprinting: correlation with fusion gene expression in the islet-derived betaTC-3 and hamster insulinoma tumor cell lines","volume":"50","author":"Bischof","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2024.09.005_bb0175","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00125-006-0564-1","article-title":"Deletion of the gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen results in a mild metabolic phenotype","volume":"50","author":"Wang","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmed.2024.09.005_bb0180","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/db12-1067","article-title":"G6PC2: a negative regulator of basal glucose-stimulated insulin secretion","volume":"62","author":"Pound","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2024.09.005_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101729","article-title":"Glucose-6-phosphatase catalytic subunit 2 negatively regulates glucose oxidation and insulin secretion in pancreatic \u03b2-cells","volume":"298","author":"Rahim","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.09.005_bb0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1530\/JME-20-0031","article-title":"Pancreatic islet beta cell-specific deletion of G6pc2 reduces fasting blood glucose","volume":"64","author":"Bosma","year":"2020","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0195","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s11892-013-0422-8","article-title":"Moving on from GWAS: functional studies on the G6PC2 gene implicated in the regulation of fasting blood glucose","volume":"13","author":"O'Brien","year":"2013","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.molmed.2024.09.005_bb0200","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diabres.2007.05.004","article-title":"Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies","volume":"78","author":"Gerstein","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.molmed.2024.09.005_bb0205","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.2337\/dc09-S309","article-title":"Plasma glucose concentration and prediction of future risk of type 2 diabetes","volume":"32","author":"Abdul-Ghani","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmed.2024.09.005_bb0210","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1038\/ncomms5639","article-title":"Reversible changes in pancreatic islet structure and function produced by elevated blood glucose","volume":"5","author":"Brereton","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.09.005_bb0215","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cmet.2014.03.010","article-title":"Pancreatic \u03b2 cell dedifferentiation in diabetes and redifferentiation following insulin therapy","volume":"19","author":"Wang","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2024.09.005_bb0220","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/ars.2010.3284","article-title":"High-glucose stimulation increases reactive oxygen species production through the calcium and mitogen-activated protein kinase-mediated activation of mitochondrial fission","volume":"14","author":"Yu","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.molmed.2024.09.005_bb0225","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/ijms22041509","article-title":"The role of oxidative stress in pancreatic \u03b2 cell dysfunction in diabetes","volume":"22","author":"Eguchi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2024.09.005_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004876","article-title":"Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus","volume":"11","author":"Mahajan","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molmed.2024.09.005_bb0235","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1038\/ncomms6897","article-title":"Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility","volume":"6","author":"Wessel","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.09.005_bb0240","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1432-1033.1978.tb12059.x","article-title":"Evidence for the involvement of a glucose-6-phosphate carrier in microsomal glucose-6-phosphatase activity","volume":"82","author":"Nilsson","year":"1978","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.molmed.2024.09.005_bb0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ymgme.2008.10.005","article-title":"Structure-function study of the glucose-6-phosphate transporter, an eukaryotic antiporter deficient in glycogen storage disease type Ib","volume":"96","author":"Pan","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2024.09.005_bb0250","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1074\/jbc.273.11.6144","article-title":"Transmembrane topology of glucose-6-phosphatase","volume":"273","author":"Pan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.09.005_bb0255","doi-asserted-by":"crossref","first-page":"32837","DOI":"10.1074\/jbc.M201853200","article-title":"The catalytic center of glucose-6-phosphatase: HIS176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis","volume":"277","author":"Ghosh","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.09.005_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1677\/jme.0.0290205","article-title":"Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein","volume":"29","author":"Martin","year":"2002","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0265","article-title":"Nonsynonymous single-nucleotide polymorphisms in the G6PC2 gene affect protein expression, enzyme activity, and fasting blood glucose","volume":"298","author":"Overway","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.09.005_bb0270","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2337\/db14-0745","article-title":"Novel stable isotope analyses demonstrate significant rates of glucose cycling in mouse pancreatic islets","volume":"64","author":"Wall","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.molmed.2024.09.005_bb0275","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1677\/joe.0.1640307","article-title":"Stable overexpression of the glucose-6-phosphatase catalytic subunit attenuates glucose sensitivity of insulin secretion from a mouse pancreatic beta-cell line","volume":"164","author":"Iizuka","year":"2000","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0280","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1677\/jme.0.0320033","article-title":"Identification and characterization of a cDNA and the gene encoding the mouse ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein","volume":"32","author":"Boustead","year":"2004","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0285","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.3390\/molecules24112184","article-title":"Antidiabetic activity and potential mechanism of amentoflavone in diabetic mice","volume":"24","author":"Su","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.molmed.2024.09.005_bb0290","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1073\/pnas.1816143116","article-title":"Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency","volume":"116","author":"Veiga-da-Cunha","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2024.09.005_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101520","article-title":"Biophysical and functional properties of purified glucose-6-phosphatase catalytic subunit 1","volume":"298","author":"Claxton","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.09.005_bb0300","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgae036","article-title":"Integrative analysis of pathogenic variants in glucose-6-phosphatase based on an AlphaFold2 model","volume":"3","author":"Sinclair","year":"2024","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.molmed.2024.09.005_bb0305","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mam.2015.09.003","article-title":"Molecular pathophysiology of hepatic glucose production","volume":"46","author":"Sharabi","year":"2015","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.molmed.2024.09.005_bb0310","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0024-3205(91)90509-A","article-title":"Metabolic intermediates as potential regulators of glucose-6-phosphatase","volume":"48","author":"Robbins","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.molmed.2024.09.005_bb0315","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-2944(85)90022-5","article-title":"Regulation of gluconeogenesis by glycerol and its phosphorylated derivatives","volume":"33","author":"Wapnir","year":"1985","journal-title":"Biochem. Med."},{"key":"10.1016\/j.molmed.2024.09.005_bb0320","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0167-4838(94)90107-4","article-title":"Time-dependent inhibition of glucose 6-phosphatase by 3-mercaptopicolinic acid","volume":"1208","author":"Foster","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2024.09.005_bb0325","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1016\/S0021-9258(17)44278-5","article-title":"3-Mercaptopicolinate. A reversible active site inhibitor of avian liver phosphoenolpyruvate carboxykinase","volume":"258","author":"Makinen","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.09.005_bb0330","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0014-5793(75)80214-6","article-title":"3-Mercaptopicolinic acid, a preferential inhibitor of the cytosolic phosphoenolpyruvate carboxykinase","volume":"58","author":"Robinson","year":"1975","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molmed.2024.09.005_bb0335","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1016\/0040-4039(96)01565-1","article-title":"7-Carbon mimics of D-glucose and L-fucose: activation by 6R-, and inactivation by 6S, -6C-methylglucose of glycogen synthase: Inhibition of glucokinase and\/or glucose-6-phosphatase","volume":"37","author":"Bl\u00e9riot","year":"1996","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.molmed.2024.09.005_bb0340","doi-asserted-by":"crossref","first-page":"941","DOI":"10.7164\/antibiotics.55.941","article-title":"Thielavins as glucose-6-phosphatase (G6Pase) inhibitors: producing strain, fermentation, isolation, structural elucidation and biological activities","volume":"55","author":"Sakemi","year":"2002","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.molmed.2024.09.005_bb0345","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1432-1033.1993.tb17782.x","article-title":"Characteristics and specificity of the inhibition of liver glucose-6-phosphatase by arachidonic acid. Lesser inhibitability of the enzyme of diabetic rats","volume":"213","author":"Mithieux","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.molmed.2024.09.005_bb0350","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.7164\/antibiotics.34.1562","article-title":"Thielavin A and B, new inhibitors of prostaglandin biosynthesis produced by Thielavia terricola","volume":"34","author":"Kitahara","year":"1981","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.molmed.2024.09.005_bb0355","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/2211-5463.12511","article-title":"Arachidonic acid suppresses hepatic cell growth through ROS-mediated activation of transglutaminase","volume":"8","author":"Qin","year":"2018","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.molmed.2024.09.005_bb0360","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/abbi.1997.0563","article-title":"Chlorogenic acid analogue S 3483: a potent competitive inhibitor of the hepatic and renal glucose-6-phosphatase systems","volume":"351","author":"Arion","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.molmed.2024.09.005_bb0365","first-page":"G1087","article-title":"Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system","volume":"274","author":"Herling","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.molmed.2024.09.005_bb0370","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.sjbs.2020.09.048","article-title":"In vivo glucose-6-phosphatase inhibitory, toxicity and antidiabetic potentials of 2-picolylamine thioureas in Swiss albino mice","volume":"27","author":"Naz","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.molmed.2024.09.005_bb0375","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1517\/13543776.11.9.1429","article-title":"Glucose-6-phosphatase inhibitors for the treatment of Type 2 diabetes","volume":"11","author":"Westergaard","year":"2001","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/j.molmed.2024.09.005_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101043","article-title":"G6PC2 confers protection against hypoglycemia upon ketogenic diet feeding and prolonged fasting","volume":"41","author":"Bosma","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.molmed.2024.09.005_bb0385","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41586-023-06693-2","article-title":"Genetic risk converges on regulatory networks mediating early type 2 diabetes","volume":"624","author":"Walker","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.09.005_bb0390","doi-asserted-by":"crossref","first-page":"13976","DOI":"10.1074\/jbc.M307756200","article-title":"Enzymatic characterization of the pancreatic islet-specific glucose-6-phosphatase-related protein (IGRP)","volume":"279","author":"Petrolonis","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2024.09.005_bb0395","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.biochi.2024.02.012","article-title":"Biochemical and metabolic characterization of a G6PC2 inhibitor","volume":"222","author":"Hawes","year":"2024","journal-title":"Biochimie"},{"key":"10.1016\/j.molmed.2024.09.005_bb0400","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tem.2019.05.004","article-title":"Gluconeogenic enzymes in beta-cells: pharmacological targets for improving insulin secretion","volume":"30","author":"Westermeier","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2024.09.005_bb0405","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s001250100479","article-title":"Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study","volume":"44","author":"Barber\u00e0","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmed.2024.09.005_bb0410","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1385\/ENDO:19:2:177","article-title":"Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes","volume":"19","author":"Fierabracci","year":"2002","journal-title":"Endocrine"},{"key":"10.1016\/j.molmed.2024.09.005_bb0415","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jcp.26913","article-title":"Sodium tungstate: Is it a safe option for a chronic disease setting, such as diabetes?","volume":"234","author":"Bertinat","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0420","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.carres.2013.08.003","article-title":"\u03b1-Bromophosphonate analogs of glucose-6-phosphate are inhibitors of glucose-6-phosphatase","volume":"381","author":"Downey","year":"2013","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.molmed.2024.09.005_bb0425","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/metabo9120282","article-title":"Glucose-6 phosphate, a central hub for liver carbohydrate metabolism","volume":"9","author":"Rajas","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.molmed.2024.09.005_bb0430","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.3390\/ijms22126403","article-title":"Role of insulin in health and disease: an update","volume":"22","author":"Rahman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2024.09.005_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.838027","article-title":"Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019","volume":"13","author":"Safiri","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.molmed.2024.09.005_bb0440","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81125-3","article-title":"Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance","volume":"92","author":"Kahn","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.09.005_bb0445","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrd.2016.151","article-title":"Targeting hepatic glucose metabolism in the treatment of type 2 diabetes","volume":"15","author":"Rines","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2024.09.005_bb0450","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1126\/science.1156849","article-title":"A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels","volume":"320","author":"Bouatia-Naji","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.molmed.2024.09.005_bb0455","first-page":"2620","article-title":"Variations in the G6PC2\/ABCB11 genomic region are associated with fasting glucose levels","volume":"118","author":"Chen","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2024.09.005_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007275","article-title":"Identification and functional analysis of glycemic trait loci in the China Health and Nutrition Survey","volume":"14","author":"Spracklen","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.molmed.2024.09.005_bb0465","article-title":"Tissue-specific alteration of metabolic pathways influences glycemic regulation","author":"Ng","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.molmed.2024.09.005_bb0470","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/bs.apcsb.2022.02.005","article-title":"Mutations in G6PC2 gene with increased risk for development of type 2 diabetes: understanding via computational approach","volume":"130","author":"Udhaya Kumar","year":"2022","journal-title":"Adv. Protein. Chem. Struct. Biol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0475","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajmg.a.33194","article-title":"Pancreatic hypoplasia presenting with neonatal diabetes mellitus in association with congenital heart defect and developmental delay","volume":"152A","author":"Balasubramanian","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.molmed.2024.09.005_bb0480","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0042-1760384","article-title":"Association of GCK (rs1799884), GCKR (rs780094), and G6PC2 (rs560887) gene polymorphisms with type 2 diabetes among Malay Ethnics","volume":"10","author":"Ansari","year":"2023","journal-title":"Glob. Med. Genet."},{"key":"10.1016\/j.molmed.2024.09.005_bb0485","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12862-017-0897-z","article-title":"Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection","volume":"17","author":"Al-Daghri","year":"2017","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.molmed.2024.09.005_bb0490","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1007\/s40618-020-01483-3","article-title":"Haplotypes of the genes (GCK and G6PC2) underlying the glucose\/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11)","volume":"44","author":"Zusi","year":"2021","journal-title":"J. Endocrinol. Investig."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424002442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424002442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T15:46:59Z","timestamp":1739375219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491424002442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1471491424002442"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2024.09.005","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of glucose-6-phosphatase activity in glucose homeostasis and its potential for diabetes therapy","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2024.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}